GR3020133T3 - Optically pure r(-) albuterol for treating asthma - Google Patents

Optically pure r(-) albuterol for treating asthma

Info

Publication number
GR3020133T3
GR3020133T3 GR960401513T GR960401513T GR3020133T3 GR 3020133 T3 GR3020133 T3 GR 3020133T3 GR 960401513 T GR960401513 T GR 960401513T GR 960401513 T GR960401513 T GR 960401513T GR 3020133 T3 GR3020133 T3 GR 3020133T3
Authority
GR
Greece
Prior art keywords
albuterol
optically pure
treating asthma
isomer
asthma
Prior art date
Application number
GR960401513T
Other languages
Greek (el)
English (en)
Inventor
Timothy J Barberich
James W Young
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23831837&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3020133(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of GR3020133T3 publication Critical patent/GR3020133T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR960401513T 1990-01-05 1996-05-31 Optically pure r(-) albuterol for treating asthma GR3020133T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46126290A 1990-01-05 1990-01-05
PCT/US1991/000088 WO1991009596A1 (en) 1990-01-05 1991-01-04 Optically pure r(-) albuterol for treating asthma

Publications (1)

Publication Number Publication Date
GR3020133T3 true GR3020133T3 (en) 1996-08-31

Family

ID=23831837

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401513T GR3020133T3 (en) 1990-01-05 1996-05-31 Optically pure r(-) albuterol for treating asthma

Country Status (11)

Country Link
US (1) US6083993A (de)
EP (1) EP0509036B1 (de)
JP (1) JP3085705B2 (de)
AT (1) ATE135908T1 (de)
AU (1) AU7174191A (de)
CA (1) CA2073181C (de)
DE (1) DE69118359T2 (de)
DK (1) DK0509036T3 (de)
ES (1) ES2085468T3 (de)
GR (1) GR3020133T3 (de)
WO (1) WO1991009596A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
AU737608B2 (en) * 1997-04-30 2001-08-23 Courage Corporation Pty Ltd Composition and methods using an eutomer
US6365756B1 (en) * 1998-02-20 2002-04-02 Fine Chemical Corporation Limited Process for the production of optically enriched (R)- or (S)-albuterol
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US7378438B2 (en) * 2002-04-19 2008-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
AU2003278565A1 (en) * 2002-10-25 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20050020692A1 (en) * 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
JP2007515402A (ja) * 2003-11-20 2007-06-14 アルターアゴン プロプライエタリー リミテッド 哺乳動物および鳥類の体脂肪および体重の減少方法
WO2005123072A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods and compositions for the treatment of pulmonary diseases
AU2005254096A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods of using albuterol and calcium activated potassium channel openers
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
WO2012087094A1 (es) * 2010-12-21 2012-06-28 Techsphere S.A. De C.V. Composición farmacéutica inhalable para el tratamiento del asma por administración vía aérea mediante un succionador de emulación de aerosol
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
EP4651867A1 (de) 2023-01-20 2025-11-26 Atrogi AB Beta 2-adrenergische rezeptoragonisten zur behandlung oder prävention von muskelschwund
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298494A (en) * 1970-06-17 1972-12-06 Allen & Hanburys Ltd Phenylethanolamine derivatives
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
EP0320550A1 (de) * 1987-12-18 1989-06-21 Bristol-Myers Company NSAID-Zusammensetzungen mit Gehalt an H1-Blockern, H2-Blockern, beta-adrenergischen Agonisten oder Mischungen hiervon und an einem Alkalinisierungsmittel
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0509036A1 (de) 1992-10-21
JPH05503102A (ja) 1993-05-27
CA2073181A1 (en) 1991-07-06
DE69118359D1 (de) 1996-05-02
WO1991009596A1 (en) 1991-07-11
AU7174191A (en) 1991-07-24
ATE135908T1 (de) 1996-04-15
DK0509036T3 (da) 1996-07-29
ES2085468T3 (es) 1996-06-01
JP3085705B2 (ja) 2000-09-11
US6083993A (en) 2000-07-04
EP0509036B1 (de) 1996-03-27
DE69118359T2 (de) 1996-08-14
CA2073181C (en) 2002-04-23

Similar Documents

Publication Publication Date Title
AU7174191A (en) Optically pure r(-) albuterol for treating asthma
DE68908722D1 (de) Dampf-Phasen-Verfahren zur Herstellung eines Diamanten.
MY121543A (en) Preparation of 3,4,4-trisubstituted-piperidinyl-n- alkylcarboxylates and intermediates
FI922434A0 (fi) Produktion av rekombinant human interleukin-1-inhibitor.
HK64994A (en) Watch glass and method for manufacturing such a glass
CA2075904A1 (en) Method of treating pre-menstrual syndrome
DE69202307D1 (de) Kryogenisches Rektifikationsverfahren zur Herstellung von gereinigtem Argon.
AU1315795A (en) Process for the preparation of an optically pure enantiomer of formoterol
EP0668125A3 (de) Verfahren zum Polieren des Umfangsrandes von Brillengläsern aus Polykarbonat oder CR39 mit Schleifscheiben aus Diamant und Vorrichtung zur Durchführung des Verfahrens.
PT724600E (pt) Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido
CA2061665A1 (en) Treatment of lower urinary tract disorders
CA2068128A1 (en) Process for the removal of olefinic impurities from 1,1,1,2,3,3,3-heptafluoropropane
ZA892744B (en) Method for the preparation of zeolites
BG104240A (en) Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
CS318483A2 (en) Zpusob vyroby 2 guanidino 4 (2 subst. amino 4 imidazolyl)thiazolu
PL313322A1 (en) Method of obtaining 9-(2-hydroxy)etyhoxymethylquanine
EP0970962A3 (de) Verfahren zur Herstellung von 2,2-Difluorketen-Silyl, 0,S-Acetale und alpha,alpha-Difluor-beta-Silyloxy-1, 3-Dioxolan-4-propansaure 0, S-estern
IL93081A (en) Method for the preparation of lacquers for color- coating contact lenses, lacquers prepared thereby and contact lenses prepared therewith
DE68909985D1 (de) Oberflächenschleifverfahren für ebene Bauteile.
AU1650292A (en) Process for obtaining dimethyl amine or trimethyl amine dehydrogenases, dehydrogenases obtained thereby and their use
AU2824289A (en) Thienotricyclene for the treatment of bronchial diseases
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
AU3385689A (en) Bonding diamond to diamond
AU2881089A (en) Abrasive and/or scouring pad, substitute for steel wool, and process for producing same
GR3024442T3 (en) Method to purify streptolysin o, intact streptolysin o obtainable by this method and its use